LMT Lombard Med.Tec

TIDMLMT

RNS Number : 7708J

Lombard Medical Technologies PLC

22 July 2013

Lombard Medical Technologies PLC

("Lombard Medical" or "Company")

Notice of Results

London, UK, 22 July 2013 - Lombard Medical Technologies PLC (AIM:LMT), the specialist medical technology company focussed on innovative vascular products, will announce its interim results for the six months ended 30 June 2013 on Thursday 29 August 2013.

-Ends-

For further information:

 
 Lombard Medical Technologies PLC                Tel: 01235 750 800 
 Simon Hubbert, Chief Executive Officer 
  Ian Ardill, Chief Financial Officer 
 
 Canaccord Genuity Limited                       Tel: 020 7523 8000 
  Lucy Tilley / Tim Redfern / Henry Fitzgerald 
  O'Connor / Dr Julian Feneley 
 
 FTI Consulting                                  Tel: 020 7831 3113 
  Simon Conway / Susan Stuart / Victoria 
  Foster Mitchell 
 

About Lombard Medical

Lombard Medical Technologies PLC (AIM: LMT), is a medical device company focused on device solutions for the $1.2 billion dollar per annum abdominal aortic aneurysm (AAA) repair market. AAAs are a balloon-like enlargement of the aorta which, if left untreated, may rupture and cause death. Approximately 4.5 million people are living with AAAs in the developed world and each year 600,000 new cases are diagnosed. The market for endovascular stent grafts for this application is expected to grow to $1.6 billion by 2015. The Company's lead product, Aorfix(TM), is an endovascular stent graft which has been specifically designed to solve the problems that exist in treating complex tortuous anatomy which is often present in advanced AAA disease. Aorfix(TM) is currently being commercialised in the EU, and has been approved by the FDA in the US, the first AAA stent graft not of US origin to gain FDA approval. The Company intends to launch Aorfix(TM) with Aorflex(TM) in the US in H2 2013; a coordinated launch event will take place at the VEITH symposium in New York City in November 2013.

The Company is headquartered in Oxfordshire, with operations in Ayrshire and Phoenix, USA.

Further background on the Company can be found at www.lombardmedical.com.

This information is provided by RNS

The company news service from the London Stock Exchange

END

NORDMGMNKLRGFZM

Lombard Medical Technologies (LSE:LMT)
Gráfico Histórico do Ativo
De Dez 2024 até Jan 2025

Lombard Medical Technologies (LSE:LMT)
Gráfico Histórico do Ativo
De Jan 2024 até Jan 2025